Peanut-Based Baby Supplements Reduce the Risk of Allergies

The ongoing US-based clinical trial Leap (Learning Early about Peanut Allergy) has found that exposure to the groundnuts during formative years reduces the likelihood of developing a hypersensitivity. Responding to this, Vini Mini has unveiled its Startkit and Follow-Up Kit, recommended for babies between four months and one year old.

Designed to be mixed in the infant’s food, the Startkit comprises capsules or sachets that contain a peanut flour dosage (that gradually increases in peanut content) suitable for a little one trying the legumes for the first time. Before beginning the treatment, parents are encouraged to complete an online test to determine the most appropriate kit for their baby. Those facing an allergic predisposition are recommended to follow a course where the dosage increments are more spread out.

After completing the Startkit, the Follow-Up Kit – a tub of 100% peanut flour alongside a measuring spoon – continues the process. One spoonful (which can be divided into smaller doses to be used throughout the week) is stirred into a baby’s food weekly for six months. This method can supposedly reduce the risk of an infant developing a peanut allergy by 80%.

Meanwhile, to combat the cost-of-living crisis and soaring inflation rates, 10% of Vini Mini’s revenues are given to low-income families to help them buy the kits, which cost €14.95 ($15.41) for the Startkit and €19.95 ($20.58) for the Follow-Up one.

Stylus members can access Feeding Baby in 2022 for more on how food brands are attempting to bolster infants’ growth and development.